Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?

about

Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?

Item

http://www.wikidata.org/entity/Q42728294

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Malignant Mesothelioma, BAP1 I ...... s and Assessment of Prognosis?

@en

Malignant Mesothelioma, BAP1 I ...... s and Assessment of Prognosis?

@nl

type

Item

label

Malignant Mesothelioma, BAP1 I ...... s and Assessment of Prognosis?

@en

Malignant Mesothelioma, BAP1 I ...... s and Assessment of Prognosis?

@nl

prefLabel

Malignant Mesothelioma, BAP1 I ...... s and Assessment of Prognosis?

@en

Malignant Mesothelioma, BAP1 I ...... s and Assessment of Prognosis?

@nl

P1476

Malignant Mesothelioma, BAP1 I ...... s and Assessment of Prognosis?

@en

P2093

David Moffat

http://www.w3.org/2001/XMLSchema#string

Douglas W Henderson

http://www.w3.org/2001/XMLSchema#string

Emily Pulford

http://www.w3.org/2001/XMLSchema#string

Kalyani Huilgol

http://www.w3.org/2001/XMLSchema#string

P2860

High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma

BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression

BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization

BAP1 is phosphorylated at serine 592 in S-phase following DNA damage

Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains

Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma.

Germline BAP1 mutations predispose to malignant mesothelioma

Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network

Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors.

P304

1310478

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/1310478

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Sonja Klebe

P577

2017-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29085180

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry

P932

5612603

http://www.w3.org/2001/XMLSchema#string